Lv4
590 积分 2023-06-06 加入
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
1个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
1个月前
已完结
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
2个月前
已完结
Diagnosis and treatment of bullous pemphigoid: an expert consensus statement （2025 edition）
2个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
2个月前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
3个月前
已完结
Loss of payload sensitivity and other mechanisms of resistance to T-DXd in HER2-mutant NSCLC: implications for subsequent responsiveness to HER2 TKIs
3个月前
已完结
Antibody-drug conjugates in oncology: A spotlight on overcoming resistance
3个月前
已完结
皖公网安备34019202002308
